WA
IRWD icon

WFG Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

WFG Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-239
Closed -$3K – 1918
2014
Q4 		$3K Hold
239
– – ﹤0.01% 1781
2014
Q3 		$3K Hold
239
– – ﹤0.01% 1793
2014
Q2 		$3K Hold
239
– – ﹤0.01% 1759
2014
Q1 		$2K Buy
+239
New +$2.69K ﹤0.01% 1804

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WFG Advisors's IRWD Position: Q1 2015 in Review

WFG Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2015, closing a stake of 239 shares — an estimated $3K sold.

WFG Advisors first reported a position in IRWD in Q1 2014 and held it in 4 quarters. The position peaked at $3K in Q4 2014. 142 funds tracked by Wall St. Rank hold IRWD as of Q1 2015.

  • WFG Advisors reported no remaining Ironwood Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • WFG Advisors sold 239 Ironwood Pharmaceuticals shares in Q1 2015, an estimated $3K.
  • WFG Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • WFG Advisors's Ironwood Pharmaceuticals position peaked at $3K in Q4 2014.
  • 142 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2015.

Based on WFG Advisors's 13F filing for Q1 2015, filed 12 May 2015.